Zenas BioPharmaZBIO

那斯達克 · USD
31.10
-1.19
(-3.69%)
收盤 09/11 03:59 (UTC+8)
09/11 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • 0.05
  • 0.10
  • -
  • -
  • -
  • -
  • 0.01
icon
  • -
  • -
  • -
  • -
  • 100.00
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
1,000
-
-
-
-
10,000
5,000
-
-
-
營業成本
----------
營業毛利
1,000
-
-
-
-
10,000
5,000
-
-
-
營業費用
108,65977,350237,98452,58055,16347,33060,62340,98539,70227,578
研發費用
62,91360,43955,72034,40143,02734,91549,15733,53033,80722,645
推銷及管理費用
15,74616,91115,59213,17912,13612,41511,4667,4555,8954,933
非經常性項目費用
30,000-166,6725,000------
其他營業費用
----------
營業利益
-77,659
-77,350
-237,984
-52,580
-55,163
-37,330
-55,623
-40,985
-39,702
-27,578
其他收入及費用
6,6192,9944,9751,0812,9603,5523,4482,378--
利息費用
10,3026,6317,327-------
稅前純益
-111,342
-80,987
-240,336
-51,499
-52,203
-33,778
-52,175
-104,384
-37,977
-27,800
所得稅
114-106-20-205429---
稅後純益
-111,456
-80,987
-240,442
-51,499
-52,223
-33,573
-52,604
-104,384
-37,977
-27,800
基本每股稅後盈餘(元)
-1.77-1.46-4.54-1.22-1.25-0.80--5.02-0.95-0.70
稀釋每股稅後盈餘(元)
-1.78-1.46-5.17-1.22-1.25-0.8016.9413.32-0.95-0.70
基本平均股數(千股)
63112.0055624.0052999.0042159.0041865.0041800.00-7697.0039792.0039792.00
稀釋平均股數(千股)
63112.0055624.0052999.0042159.0041865.0041800.00-7697.0039792.0039792.00
還原基本每股稅後盈餘(元)
-1.77-1.46-4.54-1.22-1.25-0.80--5.02-0.95-0.70
還原稀釋每股稅後盈餘(元)
-1.78-1.46-5.17-1.22-1.25-0.8016.9413.32-0.95-0.70
還原基本平均股數(千股)
63,11255,62452,99942,15941,86541,800-7,69739,79239,792
還原稀釋平均股數(千股)
63,11255,62452,99942,15941,86541,800-7,69739,79239,792
EBITDA(千元)
-102,323-74,460-233,420-51,681-53,126-34,137-52,744-104,348-37,942-27,767

大家都在看

HOT